We forecast Q1 organic revenue growth of 4.7% YOY (in line with consensus), driven by Hearing Care (we forecast 4.9%) and Diagnostics (we forecast 8.4%), while Hearing Aids faces a tough YOY comparable (we forecast 3.6%). We expect 2024 to be back-end loaded and driven by Oticon Intent. We expect maintained 2024 guidance of 4–8% organic growth, c1% M&A growth, c-1% FX, and EBIT of DKK4.6bn–5.0bn. We reiterate our BUY and DKK400 target price.
Following strong Q1 orders and earnings, we have raised our 2024–2026e clean EPS by 4% on average and our target price to EUR20 (18). We reiterate our BUY. We continue to forecast multiyear sales and earnings growth for Wärtsilä, and view it as attractively valued (see our recent report ‘Refuelled engines’).
A director at Sandvik AB bought 500,000 shares at 228.239SEK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
In the run-up to the 2024 Summer Olympic Games and Euro 2024 football tournament, we have identified six stocks to favour: JCDecaux, Accor, Sodexo, adidas, Unibail-Rodamco-Westfield and easyJet. While these two major sporting events are not expected to have a significant impact on the host economies in the medium term, the microeconomic and sectoral impacts should be more marked. The tourism, transport, beverages and consumer goods sectors are expected to be the main winners. Some med...
En amont des Jeux Olympiques d’été et de l’Euro de football 2024, nous identifions 6 valeurs à privilégier : JCDecaux, Accor, Sodexo, adidas, Unibail-Rodamco-Westfield et easyJet. Alors que ces deux évènements sportifs majeurs ne devraient pas avoir d’impact significatif sur les économies hôtes à moyen terme, les impacts microéconomiques et sectoriels devraient être plus marqués. Les secteurs du tourisme, des transports, des boissons et des biens de consommation devraient être les pr...
Q1 was weak, but management commentary suggests the issues were both expected and temporary, and should recover through the year. We are still left with some concerns – particularly the margin weakness and why the temporary issues in SMR had not been communicated if they were anticipated. Early Q2 trading comments for SMM (stable compared to Q1) do not change our view of the short cycle in general or the division in particular. We have lowered our 2024–2026e underlying adj. EBITA by 2–3%, but po...
>T1 2024 : commandes et CA en recul de 5% en organique, marge en fort recul - Sandvik a publié hier, en journée, ses résultats T1 2024 (voir détails en page suivante).Les prises de commandes étaient en recul organique de 5% yoy (-6.5% attendu par le css) avec une demande stable sur des niveaux élevés dans le secteur minier et en baisse sur les infrastructures et le secteur industriel (avec des signaux tout de même positifs, voir ci-dessous). Le CA a reculé d...
>Q1 2024: orders and revenues down 5% on an organic basis, sharp contraction in the margin - Sandvik published its Q1 2024 results yesterday (see details overleaf).The order intake was down organically by 5% y-o-y (-6.5% expected by the consensus), with stable demand at high levels in the mining sector and contracting demand in the infrastructure and industrial sectors (though with some positive signals, see hereafter). Revenues were down 5% on an organic ba...
Driven by strong brand momentum, increased investments and phased network expansion, we expect Pandora to have seen a strong start to the year (Q1 results due at 07:30 CET on 2 May). We forecast c15% organic growth YOY for Q1 (consensus c12%) and, as flagged by the company, a subdued EBIT margin due to investments. We continue to regard the full-year guidance as conservative (as has tended to be the case) and believe it could be updated with the results. We reiterate our BUY and DKK1,400 target ...
We are initiating coverage of the mining equipment segment with Metso on Outperform, Sandvik on Neutral and Epiroc on Underperform. We have adopted a cautious scenario with demand stable or slightly up in the short term (mining business sales up +3% on average between 2024 and 2026), pending positive signals indicating a rebound in greenfield investments (not before 2027, in our view). In this scenario, we think that Metso should confirm the progress achieved in 2023 (margin impr...
Nous initions le segment des équipementiers miniers avec Metso à Surperformance, Sandvik à Neutre et Epiroc à Sous-performance. Nous adoptons un scénario prudent avec une demande stable ou en légère hausse à court terme (CA des activités minières en hausse moyenne de 3% entre 2024 et 2026), dans l’attente de signaux positifs indiquant un rebond des investissements greenfield (pas avant 2027 selon nous). Dans ce scénario, nous estimons que Metso devrait confirmer les progrès réali...
We are roughly in line with consensus on Q1e and forecast broadly unchanged underlying markets QOQ. We expect comments on demand to remain solid for Mining and soft for Infrastructure, while early trading comments for daily order intake in Sandvik Manufacturing and Machining Solutions (SMM) for the first few weeks of Q2 are set to indicate it has been stable or improved slightly QOQ. We have raised our adj. EBITA 2–3% for 2024–2026e (on FX) and have raised our target price to SEK245 (225), but r...
Following a closer look, we continue to believe Pandora is positioned for strong growth. Short-term, we expect easier comparables and a market recovery; longer-term, its strategy to become known as a full jewellery company, rather than just its charms, should drive sustainably higher growth (the ‘new Pandora’). We reiterate our BUY and have raised our target price to DKK1,400 (1,150).
At its CMD, Demant updated its long-term outlook. It now targets 8–10% LCY growth (7–10%) including 6–8%-points organic growth and c2%-points M&A growth, and still sees incremental EBIT margin expansion. It expects the hearing-aid market to grow 4–6% p.a. in value (2–5%), as ASP is now guided fairly flat. We are positive on the Sirius-based Oticon Intent launch. We reiterate our BUY, and have raised our target price to DKK400 (375).
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.